2023-2029 Global Faecal Microbiota Transplant(FMT) Therapy Industry Research & Trends Analysis Report
This report aims to provide a comprehensive study of the global market for Faecal Microbiota Transplant(FMT) Therapy. Report Highlights:
(1) Global Faecal Microbiota Transplant(FMT) Therapy market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Faecal Microbiota Transplant(FMT) Therapy market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Faecal Microbiota Transplant(FMT) Therapy market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Faecal Microbiota Transplant(FMT) Therapy segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Faecal Microbiota Transplant(FMT) Therapy segment by type and by application and regional segment by type and by application.
(6) Faecal Microbiota Transplant(FMT) Therapy industry supply chain, upstream, midstream and downstream analysis.
According to YH Research, the global market for Faecal Microbiota Transplant(FMT) Therapy should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Faecal Microbiota Transplant(FMT) Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Faecal Microbiota Transplant(FMT) Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Oral segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Clostridioides Difficile Infection(CDI) has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Faecal Microbiota Transplant(FMT) Therapy include Enterome Bioscience, Rebiotix, Ritter Pharmaceuticals, Finch Therapeutics, Crestovo, Maat Pharma, Seres Therapeutics, Second Genome and OpenBiome, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Oral
Enema
Market segment by application, can be divided into
Clostridioides Difficile Infection(CDI)
Digestive System Disease
Nervous System Disease
Others
Market segment by players, this report covers
Enterome Bioscience
Rebiotix
Ritter Pharmaceuticals
Finch Therapeutics
Crestovo
Maat Pharma
Seres Therapeutics
Second Genome
OpenBiome
MicroBiome Therapeutics
1 Market Overview
1.1 Product Overview and Scope of Faecal Microbiota Transplant(FMT) Therapy
1.2 Global Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast
1.3 China Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Faecal Microbiota Transplant(FMT) Therapy Share in Global Market, 2018-2029
1.4.2 Faecal Microbiota Transplant(FMT) Therapy Market Size: China VS Global, 2018-2029
1.5 Faecal Microbiota Transplant(FMT) Therapy Market Dynamics
1.5.1 Faecal Microbiota Transplant(FMT) Therapy Market Drivers
1.5.2 Faecal Microbiota Transplant(FMT) Therapy Market Restraints
1.5.3 Faecal Microbiota Transplant(FMT) Therapy Industry Trends
1.5.4 Faecal Microbiota Transplant(FMT) Therapy Industry Policy
2 Global Competitive Situation by Company
2.1 Global Faecal Microbiota Transplant(FMT) Therapy Revenue by Company (2018-2023)
2.2 Global Faecal Microbiota Transplant(FMT) Therapy Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Faecal Microbiota Transplant(FMT) Therapy Concentration Ratio
2.4 Global Faecal Microbiota Transplant(FMT) Therapy Mergers & Acquisitions, Expansion Plans
2.5 Global Faecal Microbiota Transplant(FMT) Therapy Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Faecal Microbiota Transplant(FMT) Therapy Revenue by Company (2018-2023)
3.2 China Faecal Microbiota Transplant(FMT) Therapy Faecal Microbiota Transplant(FMT) Therapy Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Faecal Microbiota Transplant(FMT) Therapy, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Faecal Microbiota Transplant(FMT) Therapy Industry Chain
4.2 Faecal Microbiota Transplant(FMT) Therapy Upstream Analysis
4.3 Faecal Microbiota Transplant(FMT) Therapy Midstream Analysis
4.4 Faecal Microbiota Transplant(FMT) Therapy Downstream Analysis
5 Sights by Type
5.1 Faecal Microbiota Transplant(FMT) Therapy Classification
5.1.1 Oral
5.1.2 Enema
5.2 By Type, Global Faecal Microbiota Transplant(FMT) Therapy Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Faecal Microbiota Transplant(FMT) Therapy Revenue, 2018-2029
6 Sights by Application
6.1 Faecal Microbiota Transplant(FMT) Therapy Segment by Application
6.1.1 Clostridioides Difficile Infection(CDI)
6.1.2 Digestive System Disease
6.1.3 Nervous System Disease
6.1.4 Others
6.2 By Application, Global Faecal Microbiota Transplant(FMT) Therapy Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Faecal Microbiota Transplant(FMT) Therapy Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
7.3 North America
7.3.1 North America Faecal Microbiota Transplant(FMT) Therapy Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share
7.4 Europe
7.4.1 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share
7.6 South America
7.6.1 South America Faecal Microbiota Transplant(FMT) Therapy Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Faecal Microbiota Transplant(FMT) Therapy Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.3.2 By Company, U.S. Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.4.2 By Company, Europe Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.5.2 By Company, China Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2023
8.5.3 By Type, China Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.6.2 By Company, Japan Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.7.2 By Company, South Korea Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.9.2 By Company, India Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2023
8.9.3 By Type, India Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Enterome Bioscience
9.1.1 Enterome Bioscience Company Information, Head Office, Market Area and Industry Position
9.1.2 Enterome Bioscience Company Profile and Main Business
9.1.3 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.1.4 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.1.5 Enterome Bioscience Recent Developments
9.2 Rebiotix
9.2.1 Rebiotix Company Information, Head Office, Market Area and Industry Position
9.2.2 Rebiotix Company Profile and Main Business
9.2.3 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.2.4 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.2.5 Rebiotix Recent Developments
9.3 Ritter Pharmaceuticals
9.3.1 Ritter Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.3.2 Ritter Pharmaceuticals Company Profile and Main Business
9.3.3 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.3.4 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.3.5 Ritter Pharmaceuticals Recent Developments
9.4 Finch Therapeutics
9.4.1 Finch Therapeutics Company Information, Head Office, Market Area and Industry Position
9.4.2 Finch Therapeutics Company Profile and Main Business
9.4.3 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.4.4 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.4.5 Finch Therapeutics Recent Developments
9.5 Crestovo
9.5.1 Crestovo Company Information, Head Office, Market Area and Industry Position
9.5.2 Crestovo Company Profile and Main Business
9.5.3 Crestovo Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.5.4 Crestovo Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.5.5 Crestovo Recent Developments
9.6 Maat Pharma
9.6.1 Maat Pharma Company Information, Head Office, Market Area and Industry Position
9.6.2 Maat Pharma Company Profile and Main Business
9.6.3 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.6.4 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.6.5 Maat Pharma Recent Developments
9.7 Seres Therapeutics
9.7.1 Seres Therapeutics Company Information, Head Office, Market Area and Industry Position
9.7.2 Seres Therapeutics Company Profile and Main Business
9.7.3 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.7.4 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.7.5 Seres Therapeutics Recent Developments
9.8 Second Genome
9.8.1 Second Genome Company Information, Head Office, Market Area and Industry Position
9.8.2 Second Genome Company Profile and Main Business
9.8.3 Second Genome Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.8.4 Second Genome Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.8.5 Second Genome Recent Developments
9.9 OpenBiome
9.9.1 OpenBiome Company Information, Head Office, Market Area and Industry Position
9.9.2 OpenBiome Company Profile and Main Business
9.9.3 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.9.4 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.9.5 OpenBiome Recent Developments
9.10 MicroBiome Therapeutics
9.10.1 MicroBiome Therapeutics Company Information, Head Office, Market Area and Industry Position
9.10.2 MicroBiome Therapeutics Company Profile and Main Business
9.10.3 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.10.4 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.10.5 MicroBiome Therapeutics Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables and Figures
Table 1. Faecal Microbiota Transplant(FMT) Therapy Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Faecal Microbiota Transplant(FMT) Therapy Market Restraints
Table 3. Faecal Microbiota Transplant(FMT) Therapy Market Trends
Table 4. Faecal Microbiota Transplant(FMT) Therapy Industry Policy
Table 5. Global Faecal Microbiota Transplant(FMT) Therapy Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Company (2018-2023)
Table 7. Global Faecal Microbiota Transplant(FMT) Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Faecal Microbiota Transplant(FMT) Therapy Mergers & Acquisitions, Expansion Plans
Table 9. Global Faecal Microbiota Transplant(FMT) Therapy Manufacturers Product Type
Table 10. China Faecal Microbiota Transplant(FMT) Therapy Revenue by Company (2018-2023) & (US$ million)
Table 11. China Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Faecal Microbiota Transplant(FMT) Therapy Upstream (Raw Materials)
Table 13. Global Faecal Microbiota Transplant(FMT) Therapy Typical Customers
Table 14. Faecal Microbiota Transplant(FMT) Therapy Typical Distributors
Table 15. By Type, Global Faecal Microbiota Transplant(FMT) Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Faecal Microbiota Transplant(FMT) Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Faecal Microbiota Transplant(FMT) Therapy Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Faecal Microbiota Transplant(FMT) Therapy Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Faecal Microbiota Transplant(FMT) Therapy Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2029
Table 22. Enterome Bioscience Company Information, Head Office, Market Area and Industry Position
Table 23. Enterome Bioscience Company Profile and Main Business
Table 24. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
Table 25. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
Table 26. Enterome Bioscience Recent Developments
Table 27. Rebiotix Company Information, Head Office, Market Area and Industry Position
Table 28. Rebiotix Company Profile and Main Business
Table 29. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
Table 30. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
Table 31. Rebiotix Recent Developments
Table 32. Ritter Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 33. Ritter Pharmaceuticals Company Profile and Main Business
Table 34. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
Table 35. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
Table 36. Ritter Pharmaceuticals Recent Developments
Table 37. Finch Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 38. Finch Therapeutics Company Profile and Main Business
Table 39. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
Table 40. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
Table 41. Finch Therapeutics Recent Developments
Table 42. Crestovo Company Information, Head Office, Market Area and Industry Position
Table 43. Crestovo Company Profile and Main Business
Table 44. Crestovo Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
Table 45. Crestovo Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
Table 46. Crestovo Recent Developments
Table 47. Maat Pharma Company Information, Head Office, Market Area and Industry Position
Table 48. Maat Pharma Company Profile and Main Business
Table 49. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
Table 50. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
Table 51. Maat Pharma Recent Developments
Table 52. Seres Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 53. Seres Therapeutics Company Profile and Main Business
Table 54. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
Table 55. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
Table 56. Seres Therapeutics Recent Developments
Table 57. Second Genome Company Information, Head Office, Market Area and Industry Position
Table 58. Second Genome Company Profile and Main Business
Table 59. Second Genome Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
Table 60. Second Genome Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
Table 61. Second Genome Recent Developments
Table 62. OpenBiome Company Information, Head Office, Market Area and Industry Position
Table 63. OpenBiome Company Profile and Main Business
Table 64. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
Table 65. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
Table 66. OpenBiome Recent Developments
Table 67. MicroBiome Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 68. MicroBiome Therapeutics Company Profile and Main Business
Table 69. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
Table 70. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
Table 71. MicroBiome Therapeutics Recent Developments
List of Figure
Figure 1. Faecal Microbiota Transplant(FMT) Therapy Picture
Figure 2. Global Faecal Microbiota Transplant(FMT) Therapy Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Faecal Microbiota Transplant(FMT) Therapy Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Faecal Microbiota Transplant(FMT) Therapy Market Share of Global
Figure 5. Global Faecal Microbiota Transplant(FMT) Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Faecal Microbiota Transplant(FMT) Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Faecal Microbiota Transplant(FMT) Therapy Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Faecal Microbiota Transplant(FMT) Therapy Industry Chain
Figure 10. Oral
Figure 11. Enema
Figure 12. By Type, Global Faecal Microbiota Transplant(FMT) Therapy Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2029
Figure 14. Clostridioides Difficile Infection(CDI)
Figure 15. Digestive System Disease
Figure 16. Nervous System Disease
Figure 17. Others
Figure 18. By Application, Global Faecal Microbiota Transplant(FMT) Therapy Revenue, 2018-2029, US$ Million
Figure 19. By Application, Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2029
Figure 20. By Region, Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2029
Figure 21. North America Faecal Microbiota Transplant(FMT) Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2023
Figure 23. Europe Faecal Microbiota Transplant(FMT) Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2023
Figure 25. Asia Pacific Faecal Microbiota Transplant(FMT) Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2023
Figure 27. South America Faecal Microbiota Transplant(FMT) Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2018-2023
Figure 29. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Faecal Microbiota Transplant(FMT) Therapy Revenue, 2018-2029, (US$ Million)
Figure 31. By Company, U.S. Faecal Microbiota Transplant(FMT) Therapy Market Share, 2018-2023
Figure 32. By Type, U.S. Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 34. Europe Faecal Microbiota Transplant(FMT) Therapy Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, Europe Faecal Microbiota Transplant(FMT) Therapy Market Share, 2018-2023
Figure 36. By Type, Europe Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 37. By Application, Europe Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 38. China Faecal Microbiota Transplant(FMT) Therapy Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, China Faecal Microbiota Transplant(FMT) Therapy Market Share, 2018-2023
Figure 40. By Type, China Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 41. By Application, China Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 42. Japan Faecal Microbiota Transplant(FMT) Therapy Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, Japan Faecal Microbiota Transplant(FMT) Therapy Market Share, 2018-2023
Figure 44. By Type, Japan Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 45. By Application, Japan Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 46. South Korea Faecal Microbiota Transplant(FMT) Therapy Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, South Korea Faecal Microbiota Transplant(FMT) Therapy Market Share, 2018-2023
Figure 48. By Type, South Korea Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 49. By Application, South Korea Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 50. Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Market Share, 2018-2023
Figure 52. By Type, Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 53. By Application, Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 54. India Faecal Microbiota Transplant(FMT) Therapy Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, India Faecal Microbiota Transplant(FMT) Therapy Market Share, 2018-2023
Figure 56. By Type, India Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 57. By Application, India Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 58. Middle East & Asia Faecal Microbiota Transplant(FMT) Therapy Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, Middle East & Asia Faecal Microbiota Transplant(FMT) Therapy Market Share, 2018-2023
Figure 60. By Type, Middle East & Asia Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 61. By Application, Middle East & Asia Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share, 2022 VS 2029
Figure 62. Research Methodology
Figure 63. Breakdown of Primary Interviews
Figure 64. Bottom-up Approaches
Figure 65. Top-down Approaches
Reason to Buy
- Current and future of Uncategorized Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Uncategorized Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Uncategorized Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Uncategorized Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets